Innate Pharma Stock Quote IPH - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.245

Bid

2.20

Ask

2.265

Volume

61,472

2.20 Day's Range 2.26

2.11 52 Week Range 3.345

Market Cap

181.128M

Previous Close

2.18

Open

2.23

Last Trade

2.245

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

65,277

Shares Outstanding

80,860,563

Dividend Yield

PE Ratio

-23.93

Earnings Per Share (EPS)

-0.09

Revenue

61.64M

Net Profit

-7.57M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

1970

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 2.18 €. Over the last year, Innate Pharma shares have traded in a share price range of 2.11 € to 3.345 €.

Innate Pharma currently has 80,860,563 shares outstanding. The market capitalization of Innate Pharma is 181.13 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -23.93.

Innate Pharma annonce la progression de l’essai clinique évaluant le NK Cell Engager SAR443579 / IPH6101 développé par Sanofi vers la Phase 2 dans divers cancers du sang

Sanofi fait progresser SAR443579 / IPH6101, le candidat-médicament le plus avancé de la plateforme ANKET®, un NK Cell Engager trifonctionnel engageant les récepteurs NKp46/CD16 et ciblant CD123...

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

IPH45 is a novel and differentiated exatecan-Antibody Drug Conjugate targeting Nectin-4 In PDX models of urothelial tumors, IPH45 has stronger activity than approved Nectin-4 targeting EV. IPH45...

Innate Pharma Announces Its Participation in Upcoming Investor Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team are scheduled to participate in the upcoming...

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2023 Universal Registration Document (Document d’enregistrement...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.095	4.41860465116	2.15	2.265	2.11	51120	2.19926131	DE
4	0.035	1.58371040724	2.21	2.385	2.11	68218	2.23449918	DE
12	-0.14	-5.87002096436	2.385	2.44	2.11	65277	2.25797262	DE
26	-0.13	-5.47368421053	2.375	2.8	2.11	93727	2.38576284	DE
52	-0.385	-14.63878327	2.63	3.345	2.11	90144	2.54520196	DE
156	-1.255	-35.8571428571	3.5	8.3	1.986	242000	3.86779263	DE
260	-3.555	-61.2931034483	5.8	8.3	1.986	290676	4.35661542	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M